Non-Opioid Pain Patch Market Report 2024 Analysis, Key Players And Future Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Non-Opioid Pain Patch Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $4.25 billion In 2028 At A CAGR Of 4.8%.

The non-opioid pain patch market size has grown strongly in recent years. It will grow from $3.34 billion in 2023 to $3.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased chronic pain cases, patient preference for non-invasive treatment, improved formulations and ingredients, rise in sports injuries, concerns over opioid addiction.

The non-opioid pain patch market size is expected to see steady growth in the next few years. It will grow to $4.25 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing r&d investment, rising healthcare expenditure, supportive regulatory environment, consumer awareness and education, expanding geriatric population. Major trends in the forecast period include wireless and smart patch technologies, integration of natural ingredients, integration with wearable technology, biodegradable and eco-friendly patches, focus on long-lasting effects.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12230&type=smp

Non-Opioid Pain Patch Market Major Segments
The non-opioid pain patch market covered in this report is segmented -
1) By Patch: Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ket*oprofen Patches, Other Patches
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Indication: Musculoskeletal Pain, Neuropathic Pain

Key Driver - Non-Opioid Pain Patch Market Growth Fueled By Escalating Prevalence Of Chronic Pain

The rising prevalence of chronic pain is expected to propel the growth of the non-opioid pain patch market going forward. Chronic pain refers to severe pain that lasts for an extended period or coexists with another medical condition. Non-opioid pain patches are used to relieve mild to moderate pain and treat headaches, muscle aches, arthritis, backaches, and other types of pain. For instance, in May 2021, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, In the United States, adults' prevalence of chronic pain ranged from 20.5% to 21.8% between 2019 and 2021, and their prevalence of high-impact chronic pain ranged from 6.9% to 7.8%. An estimated 51.6 million American adults (20.9%) reported having chronic pain in 2021, while 17.1 million (6.9%) reported having high-impact chronic pain. Therefore, the rising prevalence of chronic pain is propelling the non-opioid pain patch market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=12230&type=smp

Prominent Trend - Product Innovations In Non-Opioid Pain Patch Market

Product innovation has emerged as a key trend gaining popularity in the non-opioid pain patch market. Major companies operating in the non-opioid pain patches market are developing innovative products to strengthen their position in the market. For instance, in June 2022, The Mentholatum Company Inc., a UK-based healthcare products manufacturer, launched Deep Relief Actiflex Patch, a drug-free pain patch. Deep Relief Actiflex Patch is a cooling hydrogel patch that contains water. It provides fast cooling and soothing relief when the water evaporates on the skin. This drug-free pain patch treats aches and pains in the muscles or joints.

Non-Opioid Pain Patch Market Players
Major companies operating in the non-opioid pain patch market report are Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Medtronic plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Aurobindo Pharma Limited, Purdue Pharma L.P., Kyowa Kirin Co. Ltd., Boehringer Ingelheim Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Endo Pharmaceuticals plc, Lupin Limited, Amneal Pharmaceuticals LLC, Daiichi Sankyo Company Limited, Glenmark Pharmaceuticals Private Limited, Mallinckrodt Pharmaceuticals LLC, IBSA Institut Biochimque SA, Teikoku Seiyaku Co.Ltd., Acorda Therapeutics Inc., Sorrento Therapeutics Inc., Veridian Healthcare LLC, Clarion Brands LLC, Averitas Pharma Inc.

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the non-opioid pain patch market in 2023. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Non-Opioid Pain Patch Market Report Structure
3. Non-Opioid Pain Patch Market Trends And Strategies
4. Non-Opioid Pain Patch Market - Macro Economic Scenario
5. Non-Opioid Pain Patch Market Size And Growth
…..
27. Non-Opioid Pain Patch Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.